Factors associated with severity and resolution of intramuscular injection site pain following treatment for uncomplicated gonorrhoea: a prospective cohort study of GToG trial participants
Oluseyi Ayinde
A B and Jonathan D. C. Ross A
+ Author Affiliations
- Author Affiliations
A Department of Sexual Health and HIV, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham, B15 2TH, UK.
B Corresponding author. Email: oluseyi.ayinde@uhb.nhs.com
Sexual Health 17(3) 255-261 https://doi.org/10.1071/SH19176
Submitted: 10 October 2019 Accepted: 30 April 2020 Published: 29 June 2020
Abstract
Background: Intramuscular injection (IMI) pain reduces the acceptability of treatment, but data identifying those at highest risk of severe pain following an injection are limited. This study identified factors associated with the severity, duration and resolution of IMI pain following treatment for uncomplicated gonorrhoea. Methods: Data from a subset of participants (aged 16–70 years) recruited between October 2014 and November 2016 into the ‘Gentamicin for the treatment of gonorrhoea’ trial in England were analysed. Pain was measured using a visual analogue scale (VAS) immediately after injection. Self-reported duration of pain was collected at a scheduled 2-week follow-up visit. Results: Overall, 688 participants (82% male), reported a median pain VAS score of 23.5 (range 0–100), which was moderate–severe (VAS score >30) in 38% (262/688) of participants. Age [adjusted odds ratio (aOR) 0.86 per 5-yearly increase, (0.78–0.94)], gender [female cf. male, aOR 1.62 (1.18–2.24)], ethnicity [Asian cf. Caucasian, aOR 2.79 (1.72–4.51)], body mass index [aOR 0.80 per 5 kgm–2 increase, (0.72–0.89)] and antibiotic regimen [gentamicin cf. ceftriaxone, aOR 3.92, (3.12–4.93)] were associated with moderate–severe injection pain. The median duration of pain was 2 h (range 0–648). Gender [female cf. male, adjusted hazard ratio (aHR) 0.76 (0.57–1.00)], ethnicity [Mixed race cf. Caucasian, aHR 0.64 (0.45–0.92)], self-reported pain [aHR 0.97 per 10 mm VAS score increase, (0.95–0.99)] and symptom status [asymptomatic cf. symptomatic aHR 1.35 (1.12–1.64)] were associated with pain resolution. Conclusions: IMI pain is influenced by specific demographic, anthropometric and clinical factors. Knowledge of these factors will help identify those most at risk of pain.
Additional keywords: gluteal injection, gonorrhoea treatment, sexual health.
References
[1] Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. British Association for Sexual Health and HIV (BASHH) national guideline for the management of infection with Neisseria gonorrhoeae. Cheshire, UK: BASHH; 2019. Availabl online at: https://www.bashhguidelines.org/media/1208/gc-2019.pdf [verified 5 July 2019].[2] Dowd FJ. Pharmacokinetics: the absorption, distribution, and fate of drugs. In Dowd FJ, Johnson BS, Mariotti AJ, editors. Pharmacology and therapeutics for dentistry, 7th edn. St Louis, MO: Mosby, Inc.; 2017. pp. 15–43.
[3] Shatsky M. Evidence for the use of intramuscular injections in outpatient practice. Am Fam Physician 2009; 79 297–300.
| 19235496PubMed |
[4] Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg 2003; 68 341–4.
| Fear of injections in young adults: prevalence and associations.Crossref | GoogleScholarGoogle Scholar | 12685642PubMed |
[5] Mroczkowski TF, Millikan LE, Martin DH, Leonik KJ. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium. Drugs Exp Clin Res 1993; 19 41–6.
| 8223139PubMed |
[6] Korting HC, Abeck D. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime. Chemotherapy 1989; 35 441–8.
| One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.Crossref | GoogleScholarGoogle Scholar | 2515041PubMed |
[7] Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, et al. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Lancet 2019; 393 2511–20.
| Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.Crossref | GoogleScholarGoogle Scholar | 31056291PubMed |
[8] Newton M, Newton DW, Fudin J. Reviewing the “big three” injection routes. Nursing 1992; 22 34–41.
| Reviewing the “big three” injection routes.Crossref | GoogleScholarGoogle Scholar | 1553072PubMed |
[9] Sartorius G, Fennell C, Spasevska S, Turner L, Conway AJ, Handelsman DJ. Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate. Asian J Androl 2010; 12 227–33.
| Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.Crossref | GoogleScholarGoogle Scholar | 20118950PubMed |
[10] Alavi NM. Effectiveness of acupressure to reduce pain in intramuscular injections. Acute Pain 2007; 9 201–5.
| Effectiveness of acupressure to reduce pain in intramuscular injections.Crossref | GoogleScholarGoogle Scholar |
[11] Chung JWY, Ng WMY, Wong TKS. An experimental study on the use of manual pressure to reduce pain in intramuscular injections. J Clin Nurs 2002; 11 457–61.
| An experimental study on the use of manual pressure to reduce pain in intramuscular injections.Crossref | GoogleScholarGoogle Scholar |
[12] Nahm FS, Lee PB, Park SY, Kim YC, Lee SC, Shin HY, et al. Pain from intramuscular vaccine injection in adults. Rev Med Chil 2012; 140 192–7.
| Pain from intramuscular vaccine injection in adults.Crossref | GoogleScholarGoogle Scholar | 22739948PubMed |
[13] Kara D, Yapucu Gunes U. The effect on pain of three different methods of intramuscular injection: a randomized controlled trial. Int J Nurs Pract 2016; 22 152–9.
| The effect on pain of three different methods of intramuscular injection: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar | 25039702PubMed |
[14] Petousis-Harris H, Jackson C, Stewart J, Coster G, Turner N, Goodyear-Smith F, et al. Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents. Hum Vaccin Immunother 2015; 11 1872–77.
| Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents.Crossref | GoogleScholarGoogle Scholar |
[15] Güneş ÜY, Kara D, Arı S, Ceyhan O. Which site is more painful in intramuscular injections? The dorsogluteal site or the ventrogluteal site? A case study from Turkey. Clin Nurs Stud 2013; 1 74–81.
| Which site is more painful in intramuscular injections? The dorsogluteal site or the ventrogluteal site? A case study from Turkey.Crossref | GoogleScholarGoogle Scholar |
[16] Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR, et al. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis 2014; 59 1083–91.
| The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.Crossref | GoogleScholarGoogle Scholar | 25031289PubMed |
[17] Hayward CJ, Nafziger AN, Kohlhepp SJ, Bertino JS. Investigation of bioequivalence and tolerability of intramuscular ceftriaxone injections by using 1% lidocaine, buffered lidocaine, and sterile water diluents. Antimicrob Agents Chemother 1996; 40 485–87.
| Investigation of bioequivalence and tolerability of intramuscular ceftriaxone injections by using 1% lidocaine, buffered lidocaine, and sterile water diluents.Crossref | GoogleScholarGoogle Scholar | 8834905PubMed |
[18] Stradling P, Kreeger LC. Optimum injection volume for intramuscular streptomycin sulphate. BMJ 1954; 2 632–3.
| Optimum injection volume for intramuscular streptomycin sulphate.Crossref | GoogleScholarGoogle Scholar | 13190217PubMed |
[19] Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001; 86 782–91.
| Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle.Crossref | GoogleScholarGoogle Scholar | 11495950PubMed |
[20] Ağaç E, Güneş UY. Effect on pain of changing the needle prior to administering medicine intramuscularly: a randomized controlled trial. J Adv Nurs 2011; 67 563–8.
| Effect on pain of changing the needle prior to administering medicine intramuscularly: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar | 21198801PubMed |
[21] Larkin TA, Ashcroft E, Hickey BA, Elgellaie A. Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites. J Clin Nurs 2018; 27 e242–50.
| Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites.Crossref | GoogleScholarGoogle Scholar | 28618093PubMed |
[22] Goffaux P, Michaud K, Gaudreau J, Chalaye P, Rainville P, Marchand S. Sex differences in perceived pain are affected by an anxious brain. Pain 2011; 152 2065–73.
| Sex differences in perceived pain are affected by an anxious brain.Crossref | GoogleScholarGoogle Scholar | 21665365PubMed |
[23] Robin O, Vinard H, Vernet-Maury E, Saumet J. Influence of sex and anxiety on pain threshold and tolerance. Funct Neurol 1987; 2 173–9.
| 3666546PubMed |
[24] Nayak S, Shiflett SC, Eshun S, Levine FM. Culture and gender effects in pain beliefs and the prediction of pain tolerance. Cross-Cultural Res 2000; 34 135–51.
| Culture and gender effects in pain beliefs and the prediction of pain tolerance.Crossref | GoogleScholarGoogle Scholar |
[25] Kemp J, Després O, Pebayle T, Dufour A. Differences in age-related effects on myelinated and unmyelinated peripheral fibres: a sensitivity and evoked potentials study. Eur J Pain 2014; 18 482–8.
| Differences in age-related effects on myelinated and unmyelinated peripheral fibres: a sensitivity and evoked potentials study.Crossref | GoogleScholarGoogle Scholar | 23996843PubMed |
[26] Rahim-Williams B, Riley JL, Williams AKK, Fillingim RB. A quantitative review of ethnic group differences in experimental pain response: do biology, psychology and culture matter? Pain Med 2012; 13 522–40.
| A quantitative review of ethnic group differences in experimental pain response: do biology, psychology and culture matter?Crossref | GoogleScholarGoogle Scholar | 22390201PubMed |
[27] Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, et al. The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 2005; 6 159–67.
| The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.Crossref | GoogleScholarGoogle Scholar | 15772909PubMed |
[28] Chan VO, Colville J, Persaud T, Buckley O, Hamilton S, Torreggiani WC. Intramuscular injections into the buttocks: are they truly intramuscular? Eur J Radiol 2006; 58 480–4.
| Intramuscular injections into the buttocks: are they truly intramuscular?Crossref | GoogleScholarGoogle Scholar | 16495027PubMed |
[29] Ogston-Tuck S. Intramuscular injection technique: an evidence-based approach. Nurs Stand 2014; 29 52–9.
| Intramuscular injection technique: an evidence-based approach.Crossref | GoogleScholarGoogle Scholar | 25249123PubMed |
[30] Şanlialp Zeyrek A, Takmak Ş, Kurban NK, Arslan S. Systematic review and meta-analysis: physical-procedural interventions used to reduce pain during intramuscular injections in adults. J Adv Nurs 2019; 75 3346–61.
| Systematic review and meta-analysis: physical-procedural interventions used to reduce pain during intramuscular injections in adults.Crossref | GoogleScholarGoogle Scholar | 31452229PubMed |
